Home Neon Therapeutics

Neon Therapeutics

acquired
IPO
Clinical-Stage Biopharmaceutical Company

Basic Information

Neon Therapeutics is a clinical-stage biopharmaceutical company. It focuses on the field of neoantigen-targeted therapies and is committed to transforming cancer treatment by directing the immune system toward neoantigens. The company's pipeline products include NEO-PV-01, NEO-PTC-01, and NEO-SV-01.
Neon Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2015
info@neontherapeutics.com